Furthermore, although virus-negative MCC is associated with worsened prognosis and differs in its tumor-specific immunity9,12,22, both virus-positive and virus-negative MCCs have shown favorable responses to immune checkpoint therapies regardless of PD-L1 expression17,19. Here, CD274 is linked to Merkel cell skin cancer.